Showing 61-70 of 1716 results for "".
Science of Skincare Summit 2024: On the FDA Approval of Emrosi for Rosacea
https://practicaldermatology.com/conferences/science-skincare-summit-2024/science-of-skincare-summit-2024-on-the-fda-approval-of-emrosi-for-rosacea/29276/At the Science of Skincare Summit in Austin, Practical Dermatology caught up with Chief Medical Editor Neal Bhatia, MD, and James Del Rosso, DO, a dermatologist and Editor in Chief of Clinical Dermatology at the Journal of Clinical and Aesthetic Dermatology (JCAD), who shared insights and thoughts oEmbracing AI
https://practicaldermatology.com/topics/practice-management/embracing-ai/20080/Artificial intelligence is something dermatologists should be embracing as augmented intelligence. Anthony Rossi, MD says this intelligence will allow us to better diagnose, assess, and treat patients with everything from acne to melanoma.DermWireTV: Nestle Skin Health Sale, Music City SCALE Highlights
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-nestle-skin-health-sale-music-city-scale-highlights/19618/A consortium led by EQT and a wholly owned subsidiary of the Abu Dhabi Investment Authority is in negotiations with Nestle for the purchase of Nestlé Skin Health for a value of10.2 billion Swiss Francs. Medical and aesthetic dermatology take center stage at Music City SCALE (Symposium for Cosmetic ABuilding a Successful Practice
https://practicaldermatology.com/topics/practice-management/building-a-successful-practice/18563/From branding tips to employee management and engagement strategies, this episode of Derm Insider focuses on how to run a successful and profitable private practice. Host Neal Bhatia, MD asks Sarah Jackson, MD and Deirdre Hooper, MD to share pearls that have led to their success at Audubon DermatolRisk In Your Portfolio
https://practicaldermatology.com/topics/practice-management/risk-in-your-portfolio/18588/Do you know your risk score? Physicians must understand their personal tolerance for risk as well as the level of risk in their current portfolios. If there is a mismatch, how do you rectify the disconnect. Bob Peelman, CFP, of OJM Group, explains. ABOUT THE AUTHORTo Be Shorr: Importance of Using Technology to Its Fullest Extent
https://practicaldermatology.com/topics/practice-management/to-be-shorr-importance-of-using-technology-to-its-fullest-extent/18605/Some of the administrative tasks that bog down a practice can be automated—and your existing vendors may have the applications and technology you need to make it happen. Be sure to investigate the services your vendors provide, many of which you already pay for, to make the most of your practice tecScience of Skincare Summit 2024: Social Media as Education Tool
https://practicaldermatology.com/conferences/science-skincare-summit-2024/science-of-skincare-summit-2024-social-media-as-education-tool/29448/Jennifer Liu, MD, a dermatologist and social media influencer (dermfluencer) talks with Practical Dermatology about using social media at a tool to educate various audiences with correct information about both products and conditions such as atopic dermatitis and psoriasis. This video was recorded aDermWire TV Extra: Dr. Bunick on BPO Study
https://practicaldermatology.com/series/dermwire-tv/dermwire-tv-extra-dr-bunick-bpo-study/29165/Practical Dermatology Editorial Board member Christopher Bunick, MD, FAAD, discusses the new Journal of Investigative Dermatology article he co-authored, "Evaluation of Benzene Presence and Formulation in Benzoyl Peroxide Drug Products."Active Vitiligo: What to Look For
https://practicaldermatology.com/series/updates-vitiligo/active-vitiligo-what-to-look-for/24156/John E. Harris, MD, founding director of the Autoimmune Therapeutics Institute at the University of Massachusetts Chan Medical School, talks with Practical Dermatology Chief Medical Editor Neal Bhatia, MD, about the clinical signs of active vitiligo.To Sell or Not to Sell to Private Equity?
https://practicaldermatology.com/conferences/scale-2023/to-sell-or-not-to-sell-to-private-equity/20195/Joel L. Cohen, MD, and George Hruza MD, discuss the pros and cons of selling to private equity. Pros include back-office support and better pricing on technology and supplies, while cons can include giving up autonomy.